DGAP-News: Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension

DGAP-News: Andera Partners / Key word(s): Financing Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension 08.06.2022 / 14:05 The issuer is solely responsible for the content of th...

Related Keywords

Paris ,France General ,France ,Munich ,Bayern ,Germany ,Philadelphia ,Pennsylvania ,United States ,Olivier Litzka ,Derek Dirocco ,Andera Croissance ,Jon Congleton ,Catalys Pacific ,Bandera Co ,Andera Life Sciences ,Mc Services ,Mitsubishi Tanabe Corporation ,Mitsubishi Tanabe Pharma Corporation ,Distribution Services ,Mineralys Therapeutics Inc ,Andera Partners ,Oversubscribed Seriesb Financing ,Mineralys Therapeutics ,Targeted Treatment ,Elevated Aldosterone ,Underlying Cause ,Hypertension Prevalent ,Significant Portion ,Mineralys Board ,Andera Life ,Rock Springs Capital ,Capital Management ,Sectoral Asset Management ,Samsara Biocapital ,Adams Street Partners ,Andrea Partners ,Chief Executive Officer ,Executive Chairman ,Andera Midcap ,Andera Expansion ,Andera Co Invest ,Andera Acto ,Andera Infra ,Bien Commun Advisory ,Corporate News ,Regulatory Announcements ,Partners ,Billion ,Oversubscribed ,Series , ,Financing ,Ineralys ,Herapeutics ,Advance ,Development ,Novel ,Argeted ,Treatment ,Hypertension ,The ,